Detection of Circulating Tumour DNA in Plasma during the Treatment of In-transit Melanoma Metastases with Topical Imiquimod
DOI:
https://doi.org/10.2340/actadv.v106.adv-2025-0229Keywords:
Melanoma, Circulating Tumor DNA, Imiquimod, Skin NeoplasmsDownloads
References
Martínez-Vila C, Teixido C, Aya F, Martín R, González-Navarro EA, Alos L, et al. Detection of circulating tumor DNA in liquid biopsy: current techniques and potential applications in melanoma. Int J Mol Sci 2025; 26: 861. DOI: https://doi.org/10.3390/ijms26020861
Genta S, Araujo DV, Hueniken K, Pipinikas C, Ventura R, Rojas P, et al. Bespoke ctDNA for longitudinal detection of molecular residual disease in high-risk melanoma patients. ESMO Open 2024; 9: 103978. DOI: https://doi.org/10.1016/j.esmoop.2024.103978
Slusher N, Jones N, Nonaka T. Liquid biopsy for diagnostic and prognostic evaluation of melanoma. Front Cell Dev Biol 2024; 12: 1420360. DOI: https://doi.org/10.3389/fcell.2024.1420360
Lucci A, Addanki S, Chiang YJ, Meas S, Sarli VN, Upshaw JR, et al. Presence of circulating tumor cells predates imaging detection of relapse in patients with stage III melanoma. Cancers 2023; 15: 3630. DOI: https://doi.org/10.3390/cancers15143630
Marchisio S, Ricci AA, Roccuzzo G, Bongiovanni E, Ortolan E, Bertero L, et al. Monitoring circulating tumor DNA liquid biopsy in stage III BRAF-mutant melanoma patients undergoing adjuvant treatment. J Transl Med 2024; 22: 1074. DOI: https://doi.org/10.1186/s12967-024-05783-7
Palacios-Diaz RD, de Unamuno-Bustos B, Carratalá-García A, Pérez-Simó G, Moreno-Ramírez D, Ferrándiz L, et al. Circulating tumor DNA predicts tumor progression and poor survival in patients with stage III melanoma. Melanoma Res 2025; 35: 259–267. DOI: https://doi.org/10.1097/CMR.0000000000001041
Scarfì F, Patrizi A, Veronesi G, Lambertini M, Tartari F, Mussi M, et al. The role of topical imiquimod in melanoma cutaneous metastases: a critical review of the literature. Dermatol Ther 2020; 33: e14165. DOI: https://doi.org/10.1111/dth.14165
Kumar AB, Jakub JW, Lester SC, Markovic SN, Baum CL. In-transit melanoma metastases: evaluation and management for the dermatologist. J Am Acad Dermatol 2025; 93: 188–195. DOI: https://doi.org/10.1016/j.jaad.2025.03.005
El-Khattouti A, Selimovic D, Hannig M, Taylor EB, Abd Elmageed ZY, Hassan SY, et al. Imiquimod-induced apoptosis of melanoma cells is mediated by ER stress-dependent Noxa induction and enhanced by NF-κB inhibition. J Cell Mol Med 2016; 20: 266–286. DOI: https://doi.org/10.1111/jcmm.12718
Di Nardo L, Del Regno L, Di Stefani A, Mannino M, Fossati B, Catapano S, et al. The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients. Exp Dermatol 2023; 32: 1785–1793. DOI: https://doi.org/10.1111/exd.14901
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
